Assertio Holdings shares rise 11.32% intraday after reporting Q4 2025 results above expectations and providing 2026 guidance reflecting strategic shift to oncology and cost optimization.

martes, 24 de marzo de 2026, 11:47 am ET1 min de lectura
ASRT--
Assertio Holdings surged 11.32% intraday, driven by its Q4 2025 financial results showing $13.54 million in revenue (down 57.9% YoY but exceeding expectations) and 2026 guidance projecting $110M-$125M in net product sales and $28M-$40M in adjusted EBITDA, reflecting a strategic shift to oncology and cost optimization.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios